Invasive mole is a rare subgroup of gestational trophoblastic disease characterized by the invasion of molar tissue into the myometrium or uterine vasculature. In this paper, we report the third case of invasive mole described in the Malagasy literature. A 33-year-old woman was referred to the Soavinandriana Hospital, her complaint was persistent vaginal bleeding during 2 months, occurring at 3 months of pregnancy with biological anemia without hemodynamic repercussions. The human chorionic gonadotropin (HCG) level was 385,931 mIU/ml. A haemostasis hysterectomy was performed. Histological examination showed an enlarged uterus and endometrial cavity containing edematous chorionic villi with trophoblastic proliferation invading the myometrium. The diagnosis was an invasive mole, stage I, FIGO score 6. Chemotherapy was prescribed but was not honored. After 45 days of follow-up, the serum βHCG level decreased to 1803 mIU/ml, without clinical symptoms. The patient then lost sight. Persistent vaginal bleeding after pregnancy may be the only clinical symptom of an invasive mole and should raise suspicion. Histological examination establishes the diagnosis. As this is an unusual cause of vaginal bleeding, our case should remind physicians that when faced with this symptom, the possibility of an invasive mole should be considered in order to make an early diagnosis for less aggressive treatment.
References
[1]
Alpaslan, A., Memet, S. and Özlem, Ü. (2016) Giant Invasive Mole Presenting as a Cause of Abdominopelvic Mass in a Perimenopausal Woman: An Unusual Presentation of a Rare Pathology. Obstetrics & Gynecology Science, 59, 548-553. https://doi.org/10.5468/ogs.2016.59.6.548
[2]
Soheila, A. and Andisheh, M. (2017) Unusual Presentation of Invasive Mole: A Case Report. Journal of Reproduction & Infertility, 18, 205-209.
[3]
Rajaonera, R. and Franco, R. (1965) Le problème de la dégénérescence post-molaire: A propos d’un diagnostic de chorioadénomadestruens. Ann de l’Univ de Mad (Médecine), 3, 25-28.
[4]
Rabarikoto, H.F., Hasiniatsy, N.R.E., Razafindrafara, H.E. and Randriambololona, D.M.A. (2018) Invasive Mole Complicating a Spontaneous Abortion. ARC Journal of Gynecology and Obstetrics, 3, 21-24.
[5]
Rahaoui, M., Zizi, H., Mamouni, N., et al. (2020) Les moles invasives : présentations cliniques et prise en charge thérapeutique. (A propos de deux cas et revue de la littérature). International Journal of Advanced Research, 8, 129-145. https://doi.org/10.21474/IJAR01/10607
[6]
Sebire, N.J., Fisher, N.A., Foskett, M., Rees, H., Seckl, M.J. and Newlands, E.S. (2003) Risk of Recurrent Hydatiform Mole and Subsequent Pregnancy Outcome Following Complete or Partial Hydatiform Molar Pregnancy. An International Journal of Obstetrics and Gynaecology, 110, 22-26. https://doi.org/10.1046/j.1471-0528.2003.02388.x
[7]
Bouvier, R., Carles, D., Dauge, M.Ch., et al. (2008) Pathologie foetale et placentaire pratique. Ouvrage collectif de la société française de foetopathologie.
[8]
Zhou, Q., Lei, X.-Y., Xie, Q. and Cardoza, J.D. (2005) Sonographic and Doppler Imaging in the Diagnosis and Treatment of Gestational Trophoblastic Disease: A 12-Year Experience. Journal of Ultrasound in Medicine, 24, 15-24. https://doi.org/10.7863/jum.2005.24.1.15
[9]
FIGO Oncology Committee (2002) FIGO Staging for Gestational Trophoblastic Neoplasia 2000. International Journal of Gynecology & Obstetrics, 77, 285-287. https://doi.org/10.1016/S0020-7292(02)00063-2
[10]
Seckl, M.J., Sebire, N.J., Fisher, R.A., Golfier, F., et al. (2013) Gestational Trophoblastic Disease: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 24, 39-50. https://doi.org/10.1093/annonc/mdt345
[11]
Niemann, I., Vejerslev, L.O., Froding, L., Blaakaer, J., et al. (2015) Gestational Trophoblastic Diseases-Clinical Guidelines for Diagnosis, Treatment, Follow-Up, and Counseling. Danish Medical Journal, 62, A5082.